Topic prioritisation
Showing 1 to 2 of 2
| Title | Prioritisation routing | Decision | Decision date |
|---|---|---|---|
| Macitentant–tadalafil for treating pulmonary arterial hypertension [TSID10517] | None selected | Not selected | |
| Atezolizumab with cabozantinib for treating metastatic non-small-cell lung cancer after platinum-based chemotherapy and 1 PD-L1 checkpoint inhibitor TSID 11812 | None selected | n/a | TBC |